Outsourced Pharma Capabilities Update – Large Molecule at our Milford, MA Site

Oct 07, 2026

Large molecule development requires the right expertise, strategy, and manufacturing foundation from the start.

Posted by Rentschler Biopharma Inc

Large molecule development requires the right expertise, strategy, and manufacturing foundation from the start. 
 
In our latest Expert Insights video, Detra G., our Head of Business Development U.S., revisits key takeaways from her Outsourced Pharma Capabilities Update (OPCU) presentation, sharing perspectives on large molecule development and the role of our Milford site in supporting biologics programs from development through manufacturing. 
 
Watch the on-demand session to explore key considerations for large molecule development, manufacturing readiness, and building a reliable path toward clinical and commercial success. 
 
Watch the full on-demand session here: https://lnkd.in/e5XNTv2n

See all Member News